We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common use of Efficacy Clause in Contracts

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 4 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.

Appears in 1 contract

Samples: Supply Agreement (NUCRYST Pharmaceuticals Corp.)

AutoNDA by SimpleDocs

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 4 hours 30 minutes achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8WI-8.2.4-2.033. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034.

Appears in 1 contract

Samples: Supply Agreement (NUCRYST Pharmaceuticals Corp.)

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 4 2 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8WI-8.2.4-2.017. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034.

Appears in 1 contract

Samples: Supply Agreement (NUCRYST Pharmaceuticals Corp.)

AutoNDA by SimpleDocs

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 4 2 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.

Appears in 1 contract

Samples: Supply Agreement (NUCRYST Pharmaceuticals Corp.)